- Consumer Products
- Latest 5.80
- Currency US$
- Change 0.36
- Percent Change 6.618 %
- Volume 8,127,571
- Mon Oct 20, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
12 months ended Mar 31, 2014.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Aug 6||$-0.27||Nov 5||$-0.30|
12 months ended Oct 20, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Ariad Pharmaceuticals is engaged in the discovery and development of novel pharmaceuticals based on intracellular signaling technology. The Company has established highly integrated capabilities in functional genomics, molecular cell biology, structure based drug design, combinatorial chemistry and pharmacology. The company is developing small-molecule drugs that block signal transduction pathways in cells responsible for osteoporosis, and immune and inflammatory diseases.